MTHFR, TYMS and SLCO1B1 Polymorphisms and Adverse Liver Effects of Methotrexate in Rheumatoid Arthritis

References

• Bedoui Y , GuillotX , SelambaromJet al. Methotrexate an old drug with new tricks. Int. J. Mol. Sci.20(20), doi:10.3390/ijms20205023 (2019).
   PubMed Web of Science ®Google Scholar
• Aletaha D , FunovitsJ , KeystoneEC , SmolenJS. Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patients. Arthritis Rheum.56(10), 3226–3235 (2007).
   PubMedGoogle Scholar
• Karlsson Sundbaum J , ErikssonN , HallbergP , LehtoN , WadeliusM , BaecklundE. Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: a long-term follow-up of predictors, surveillance, and outcome in clinical practice. Int. J. Rheum. Dis.22(7), 1226–1232 (2019).
   PubMed Web of Science ®Google Scholar
• Stamp LK , RobertsRL. Effect of genetic polymorphisms in the folate pathway on methotrexate therapy in rheumatic diseases. Pharmacogenomics12(10), 1449–1463 (2011).
   PubMed Web of Science ®Google Scholar
• Chen Y , ZouK , SunJ , YangY , LiuG. Are gene polymorphisms related to treatment outcomes of methotrexate in patients with rheumatoid arthritis? A systematic review and meta-analysis. Pharmacogenomics18(2), 175–195 (2017).
   PubMed Web of Science ®Google Scholar
• Blits M , JansenG , AssarafYGet al. Methotrexate normalizes up-regulated folate pathway genes in rheumatoid arthritis. Arthritis Rheum.65(11), 2791–2802 (2013).
   PubMedGoogle Scholar
• Song GG , BaeSC , LeeYH. Association of the MTHFR C677T and A1298C polymorphisms with methotrexate toxicity in rheumatoid arthritis: a meta-analysis. Clin. Rheumatol.33(12), 1715–1724 (2014).
   PubMed Web of Science ®Google Scholar
• Wessels JA , de Vries-BouwstraJK , HeijmansBTet al. Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes. Arthritis Rheum.54(4), 1087–1095 (2006).
   PubMedGoogle Scholar
• Soukup T , DosedelM , PavekPet al. The impact of C677T and A1298C MTHFR polymorphisms on methotrexate therapeutic response in east Bohemian region rheumatoid arthritis patients. Rheumatol. Int.35(7), 1149–1161 (2015).
   PubMed Web of Science ®Google Scholar
• Berkani LM , RahalF , AllamI , MouakiBenani S , LaadjouzA , DjidjikR. Association of MTHFR C677T and A1298C gene polymorphisms with methotrexate efficiency and toxicity in Algerian rheumatoid arthritis patients. Heliyon3(11), e00467 (2017).
   PubMedGoogle Scholar
• te Loo DM , HagleitnerMM , CoenenMJ. Is there a role for the MTHFR 677C>T and 1298A>C polymorphisms in methotrexate-induced liver toxicity?Pharmacogenomics15(11), 1401–1403 (2014).
   PubMed Web of Science ®Google Scholar
• Bae SC , LeeYH. TYMS polymorphisms and responsiveness to or toxicity of methotrexate in rheumatoid arthritis. Z. Rheumatol.77(9), 824–832 (2018).
   PubMed Web of Science ®Google Scholar
• Horie N , AibaH , OguroK , HojoH , TakeishiK. Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5′-terminal regulatory region of the human gene for thymidylate synthase. Cell Struct. Funct.20(3), 191–197 (1995).
   PubMed Web of Science ®Google Scholar
• Lima A , SeabraV , BernardesM , AzevedoR , SousaH , MedeirosR. Role of key TYMS polymorphisms on methotrexate therapeutic outcome in Portuguese rheumatoid arthritis patients. PLoS ONE9(10), e108165 (2014).
   PubMed Web of Science ®Google Scholar
• Jekic B , LukovicL , BunjevackiVet al. Association of the TYMS 3G/3G genotype with poor response and GGH 354GG genotype with the bone marrow toxicity of the methotrexate in RA patients. Eur. J. Clin. Pharmacol.69(3), 377–383 (2013).
   PubMed Web of Science ®Google Scholar
• Qiu Q , HuangJ , ShuX , FanH , ZhouY , XiaoC. Polymorphisms and pharmacogenomics for the clinical efficacy of methotrexate in patients with rheumatoid arthritis: a systematic review and meta-analysis. Sci. Rep.7, 44015 (2017).
   PubMed Web of Science ®Google Scholar
• Chen Y , ShenZ. Gene polymorphisms in the folate metabolism and their association with MTX-related adverse events in the treatment of ALL. Tumour Biol.36(7), 4913–4921 (2015).
   PubMedGoogle Scholar
• Yang L , WuH , GelderTVet al. SLCO1B1 rs4149056 genetic polymorphism predicting methotrexate toxicity in Chinese patients with non-hodgkin lymphoma. Pharmacogenomics18(17), 1557–1562 (2017).
   PubMed Web of Science ®Google Scholar
• Eldem I , YavuzD , CumaogullariOet al. SLCO1B1 polymorphisms are associated with drug intolerance in childhood leukemia maintenance therapy. J. Pediatr. Hematol. Oncol.40(5), e289–e294 (2018).
   PubMed Web of Science ®Google Scholar
• Lima A , BernardesM , AzevedoRet al. SLC19A1, SLC46A1 and SLCO1B1 polymorphisms as predictors of methotrexate-related toxicity in Portuguese rheumatoid arthritis patients. Toxicol. Sci.142(1), 196–209 (2014).
   PubMed Web of Science ®Google Scholar
• Svensk reumatologisk Förening. (2017). https://svenskreumatologi.se/grupper/arbetsgrupper/riktlinjer-for-saker-lakemedelsbehandling-vid-reumatisk-sjukdom/
   Google Scholar
• Rustad P , FeldingP , FranzsonLet al. The Nordic reference interval project 2000: recommended reference intervals for 25 common biochemical properties. Scand. J. Clin. Lab. Invest.64(4), 271–284 (2004).
   PubMed Web of Science ®Google Scholar
• Robien K , UlrichCM , BiglerJet al. Methylenetetrahydrofolate reductase genotype affects risk of relapse after hematopoietic cell transplantation for chronic myelogenous leukemia. Clin. Cancer Res.10(22), 7592–7598 (2004).
   PubMed Web of Science ®Google Scholar
• Austin PC , SteyerbergEW. Interpreting the concordance statistic of a logistic regression model: relation to the variance and odds ratio of a continuous explanatory variable. BMC Med. Res. Methodol.12, 82–82 (2012).
   PubMed Web of Science ®Google Scholar
• Schmajuk G , MiaoY , YazdanyJ , BoscardinWJ , DaikhDI , SteinmanMA. Identification of risk factors for elevated transaminases in methotrexate users through an electronic health record. Arthritis Care Res. (Hoboken)66(8), 1159–1166 (2014).
   PubMed Web of Science ®Google Scholar
• Weisberg I , TranP , ChristensenB , SibaniS , RozenR. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol. Genet. Metab.64(3), 169–172 (1998).
   PubMed Web of Science ®Google Scholar
• Mena JP , Salazar-ParamoM , Gonzalez-LopezLet al. Polymorphisms C677T and A1298C in the MTHFR gene in Mexican patients with rheumatoid arthritis treated with methotrexate: implication with elevation of transaminases. Pharmacogenomics J.11(4), 287–291 (2011).
   PubMed Web of Science ®Google Scholar
• Lv S , FanH , LiJet al. Genetic polymorphisms of TYMS, MTHFR, ATIC, MTR, and MTRR are related to the outcome of methotrexate therapy for rheumatoid arthritis in a Chinese population. Front. Pharmacol.9, 139030 (2018).
   Web of Science ®Google Scholar
• Wang S , ZuoS , LiuZ , JiX , YaoZ , WangX. Association of MTHFR and RFC1 gene polymorphisms with methotrexate efficacy and toxicity in Chinese han patients with rheumatoid arthritis. J. Int. Med. Res. 300060519879588 (2019).
   Web of Science ®Google Scholar
• Owen SA , LuntM , BowesJet al. MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphisms. Pharmacogenomics J.13(2), 137–147 (2013).
   PubMed Web of Science ®Google Scholar
• Tasbas O , BormanP , GurhanKarabulut H , TukunA , YorganciogluR. The frequency of A1298C and C677T polymorphisms of the methylentetrahydrofolate gene in Turkish patients with rheumatoid arthritis: relationship with methotrexate toxicity. Open Rheumatol. J.5, 30–35 (2011).
   PubMedGoogle Scholar
• Plaza-Plaza JC , AguileraM , Canadas-GarreMet al. Pharmacogenetic polymorphisms contributing to toxicity induced by methotrexate in the southern Spanish population with rheumatoid arthritis. OMICS16(11), 589–595 (2012).
   PubMed Web of Science ®Google Scholar
• Davis LA , PolkB , MannAet al. Folic acid pathway single nucleotide polymorphisms associated with methotrexate significant adverse events in united states veterans with rheumatoid arthritis. Clin. Exp. Rheumatol.32(3), 324–332 (2014).
   PubMed Web of Science ®Google Scholar
• Borman P , TasbasO , KarabulutH , TukunA , YorganciogluR. Thymidylate synthase genetic polymorphism and plasma total homocysteine level in a group of Turkish patients with rheumatoid arthritis: Relationship with disease activity and methotrexate toxicity. Rev. Bras. Reumatol.55(6), 485–492 (2015).
   PubMedGoogle Scholar
• Muralidharan N , MisraDP , JainVK , NegiVS. Effect of thymidylate synthase (TYMS) gene polymorphisms with methotrexate treatment outcome in south Indian tamil patients with rheumatoid arthritis. Clin. Rheumatol.36(6), 1253–1259 (2017).
   PubMed Web of Science ®Google Scholar
• Chaabane S , MarzoukS , AkroutRet al. Genetic determinants of methotrexate toxicity in Tunisian patients with rheumatoid arthritis: a study of polymorphisms involved in the MTX metabolic pathway. Eur. J. Drug Metab. Pharmacokinet.41(4), 385–393 (2016).
   PubMed Web of Science ®Google Scholar
• Trevino LR , ShimasakiN , YangWet al. Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects. J. Clin. Oncol.27(35), 5972–5978 (2009).
   PubMed Web of Science ®Google Scholar
• Ramsey LB , PanettaJC , SmithCet al. Genome-wide study of methotrexate clearance replicates SLCO1B1. Blood121(6), 898–904 (2013).
   PubMed Web of Science ®Google Scholar
• Wang Z , ZhangN , ChenCet al. Influence of the OATP polymorphism on the population pharmacokinetics of methotrexate in Chinese patients. Curr. Drug Metab.20(7), 592–600 (2019).
   PubMed Web of Science ®Google Scholar
• Choe JY , LeeH , JungHY , ParkSH , BaeSC , KimSK. Methylenetetrahydrofolate reductase polymorphisms, C677T and A1298C, are associated with methotrexate-related toxicities in korean patients with rheumatoid arthritis. Rheumatol. Int.32(6), 1837–1842 (2012).
   PubMed Web of Science ®Google Scholar
• Jenko B , LusaL , TomsicM , PraprotnikS , DolzanV. Clinical–pharmacogenetic predictive models for MTX discontinuation due to adverse events in rheumatoid arthritis. Pharmacogenomics J.17(5), 412–418 (2017).
   PubMed Web of Science ®Google Scholar
• Eektimmerman F , AllaartCF , HazesJMet al. Validation of a clinical pharmacogenetic model to predict methotrexate nonresponse in rheumatoid arthritis patients. Pharmacogenomics20(2), 85–93 (2019).
   PubMed Web of Science ®Google Scholar
• Caliz R , del AmoJ , BalsaAet al. The C677T polymorphism in the MTHFR gene is associated with the toxicity of methotrexate in a Spanish rheumatoid arthritis population. Scand. J. Rheumatol.41(1), 10–14 (2012).
   PubMed Web of Science ®Google Scholar
• van Ede AE , LaanRF , BlomHJet al. The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients. Arthritis Rheum.44(11), 2525–2530 (2001).
   PubMed Web of Science ®Google Scholar
• Swierkot J , SlezakR , KarpinskiPet al. Associations between single-nucleotide polymorphisms of RFC-1, GGH, MTHFR, TYMS, and TCII genes and the efficacy and toxicity of methotrexate treatment in patients with rheumatoid arthritis. Pol. Arch. Med. Wewn.125(3), 152–161 (2015).
   PubMed Web of Science ®Google Scholar
• Bohanec Grabar P , LogarD , LestanB , DolzanV. Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism. Eur. J. Clin. Pharmacol.64(11), 1057–1068 (2008).
   PubMed Web of Science ®Google Scholar